insights_auto
Why is MOLN up 2.81%?
Dive Deeperchevron_right
MOLN:NASDAQ
Molecular Partners AG
$3.66
arrow_upward
+2.81%(+0.10) 1D
Oct 19, 12:53:37 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
$3.75
High
$3.75
Low
$3.66
Mkt. cap
156.18M
Avg. vol.
1.47K
Volume
879.00
52-wk high
$5.36
52-wk low
$3.52
EPS
-$1.66
Beta
1.03
Shares outstanding
40.38M
No. of employees
134
Open
$3.75
High
$3.75
Low
$3.66
Mkt. cap
156.18M
Avg. vol.
1.47K
Volume
879.00
52-wk high
$5.36
52-wk low
$3.52
EPS
-$1.66
Beta
1.03
Shares outstanding
40.38M
No. of employees
134
News stories
From web sources and news partners
TradingView
·
25 minutes ago
Midday Pulse: S&P 500 top intraday losers
bloomingbit
·
1 hour ago
U.S. Stocks Turn Higher; Nasdaq Up 1.36%
Investor's Business Daily
·
27 minutes ago
Magnificent Seven Are Losing Their Earnings Luster
24/7 Wall St.
·
1 hour ago
S&P 500 Climbs to 7,721 at Midday, Led by a Tech-Heavy Surge
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG